Table 3 Analysis of the factors associated with improvement of functional score among the patients receiving proximal femoral fracture fixation surgery (n = 126)

Age

0.00 (-0.03, 0.03)

0.868

0.01 (-0.02, 0.04)

0.614

-0.10 (-0.30, 0.09)

0.284

-0.07 (-0.26, 0.12)

0.447

Sex (Male vs. Female)

-1.04 (-1.81, -0.27)

0.009*

-1.11 (-2.01, -0.20)

0.018*

-2.14 (-2.32, -0.74)

0.021*

-1.66 (-2.14, -0.60)

0.016*

BMI

0.00 (-0.08, 0.08)

0.930

-0.05 (-0.13, 0.04)

0.272

-0.07 (-0.55, 0.40)

0.764

0.38 (-0.18, 0.93)

0.181

Medication (Forteo vs. Prolia)

4.76 (-0.30, 9.82)

0.002*

2.07 (1.50, 4.65)

0.002*

3.91 (0.90, 8.71)

0.009*

6.80 (1.04, 12.56)

0.021*

FRAX major

0.01 (-0.01, 0.04)

0.331

0.07 (-0.10, 0.24)

0.407

FRAX hip

0.01 (-0.02, 0.04)

0.600

0.10 (-0.09, 0.30)

0.302

Previous medicine

-

-

-

-

-

-

 None

Ref.

Ref.

Ref.

Ref.

Ref.

Ref.

 Prolia

0.61 (-0.23, 1.45)

0.154

-0.11 (1.70, 2.49)

0.720

0.95 (-0.37, 1.27)

0.067

 Bisphosphonate

-0.02 (-0.88, 0.85)

0.969

1.38 (-3.82, 6.57)

0.598

-0.15 (-5.65, 5.35)

0.956

Dyslipidemia vs. None

-0.57 (-1.45, 0.31)

0.200

-1.53 (-6.91, 3.84)

0.570

HTN vs. None

0.31 (-0.32, 0.94)

0.327

0.36 (-3.45, 4.16)

0.852

DM vs. None

0.26 (-0.52, 1.04)

0.501

-2.52 (-7.20, 2.16)

0.286

CKD vs. None

-0.63 (-1.46, 0.20)

0.136

3.06 (-2.01, 8.12)

0.232

CAD vs. None

-0.98 (-1.89, -0.07)

0.035*

-0.79 (-1.80, 0.22)

0.123

-2.41 (-8.09, 3.26)

0.399